Samsung Biologics
207940.KS
$568.43
Share price
-1.27%
Change (1 day)
-5.19%
Change (1 year)
Categories
Earnings for Samsung Biologics (207940.KS)
Earnings in 2023 (TTM): $0.91 B
According to Samsung Biologics 's latest financial reports the company's current earnings (TTM) are $0.91 B. In 2022 the company made an earning of $0.83 B an increase over its 2021 earnings that were of $0.49 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Samsung Biologics from 2016 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $0.91 B | 9.77% |
| 2022 | $0.83 B | 67.66% |
| 2021 | $0.49 B | 103.97% |
| 2020 | $0.24 B | 57.39% |
| 2019 | $0.15 B | -45.46% |
| 2018 | $0.28 B | -390% |
| 2017 | -$97.66 M | -46.74% |
| 2016 | -$0.19 B |